TER

Business profile & competitive position

Teradyne, Inc. sits in the Technology sector, within the Semiconductors industry. The company designs and supplies automated test equipment and robotics solutions, with its core business tied to testing the chips and electronic systems that power everything from smartphones to data-center hardware. A net margin of 25.8% and a return on equity of 38.0% are the most telling competitiveness signals in the profile. Margins at that level suggest Teradyne holds meaningful pricing power in its niches and can convert revenue into profit even during periods of capital-equipment cyclicality. An ROE of 38.0% further implies that management is deploying shareholder capital efficiently, generating outsized returns relative to the equity base. Taken together, these figures point to a business with a defendable position in semiconductor testing, though the numbers alone do not specify the exact width of that moat or how it compares peer-for-peer across every product line.

Financial posture

Teradyne currently carries a market capitalization of $57.7 billion and trades at a P/E ratio of 50.3 — a multiple that prices in substantial future earnings growth. That valuation looks less daunting when set against a 25.8% net margin and 38.0% ROE, both of which sit well above what most industrial or hardware companies produce. Still, a P/E above 50 means the stock is priced for perfection; any slowdown in semiconductor capital expenditures or a miss on profitability expectations can compress the multiple quickly. The beta of 1.79 is another key figure: Teradyne has historically moved roughly 1.79% for every 1% move in the broader market, so the stock behaves as a high-volatility, cyclical technology name rather than a defensive holding. At $368.78, the price sits almost exactly at the 50-day EMA of $370.48, while the RSI of 49.8 reads neutral — neither overbought nor oversold.

Macro & geopolitical exposure

Because Teradyne is classified as a Semiconductor industry name, its macro profile is dominated by capital-spending cycles, trade policy, and supply-chain geography. Semiconductor test equipment is a late-cycle capital good: demand surges when chipmakers expand capacity and contracts when those same manufacturers freeze capex. That makes the business sensitive to global manufacturing PMI, memory pricing, and foundry utilization rates. Trade policy is another real exposure: test equipment is frequently shipped across borders, and tariffs or export restrictions on advanced semiconductors can indirectly dampen the addressable market. Currency matters too — a stronger U.S. dollar can pressure overseas revenue translation, while a weaker dollar can help. Geopolitically, any restriction on semiconductor sales into China or retaliatory measures affecting U.S. equipment vendors would ripple through Teradyne's order book, even though the data here does not quantify that specific geographic revenue split.

Recent developments

The latest headlines capture the cross-currents around the stock. On August 7, 2026, Benzinga reported that a weak jobs report sparked a rally in AI and tech names, listing Teradyne among the stocks leading Friday's surge. Two days earlier, on August 5, 2026, Zacks published a piece titled "Why Teradyne (TER) Might be Well Poised for a Surge," while the same outlet ran a contradictory headline on August 4, 2026: "Teradyne Is Overvalued at 10.36X PS: Should You Still Buy the Stock?" Also on August 5, 2026, 247wallst.com covered Elon Musk's prediction that "Money Won't Matter in 2036." That last item is more macro-colored than company-specific, but it shows the AI-centric fascination that has lifted many semiconductor names. The tension in the coverage — one article flagging overvaluation at 10.36x price-to-sales, another flagging surge potential — mirrors the valuation-versus-growth debate embedded in the 50.3 P/E.

Earnings behavior & post-earnings drift

Teradyne's earnings history is unusually strong on the headline numbers. Over the last eight reported quarters, the company has beaten estimates every single time, for a 100% beat rate, with an average earnings surprise of 15.3%. The post-earnings drift is also strongly positive: the average 5-day price move after earnings across those quarters is 16.43%, classified as "up." But the recent quarter-by-quarter track record shows the path is rarely smooth. On July 28, 2026, Teradyne reported EPS of $2.47 against an estimate of $2.09, an 18.2% beat, yet the stock dipped 0.39% the next day before rallying 25.86% over the following five sessions. The April 28, 2026 quarter was even more jarring: EPS of $2.56 versus $2.11 (a 21.3% beat) was followed by a 19.41% drop the next day and a 5-day decline of 6.06%. By contrast, the February 2, 2026 report delivered a 30.4% surprise ($1.80 vs. $1.38) and produced a 13.41% next-day gain and a 24.24% five-day gain. The October 28, 2025 report, with a smaller 7.6% beat ($0.85 vs. $0.79), still rallied 20.47% the next day and 21.66% over five days. The takeaway is that beating estimates has been the norm, but the immediate market reaction is not guaranteed to be positive. The next scheduled report is October 27, 2026, after the close, with a consensus EPS estimate of $2.03. That figure represents the market's real expectation heading into the print, and any deviation from it will likely drive the post-earnings price action.

For a deeper dive into how buy-side and sell-side institutions are currently weighing these same factors, readers should review the full institutional verdict on Teradyne.